Rare disease biotech with eight approved therapies and a genetics-driven pipeline
BioMarin is a public biotech company developing genetic therapies for rare diseases, built on a foundation of eight approved treatments. The tech stack—SAP, Veeva QMS, Salesforce Health Cloud, LIMS, and emerging AI tools (Claude, GPT)—reflects a manufacturing and regulatory-heavy organization managing complex supply chains, clinical data, and compliance at scale. Active projects center on SAP S/4HANA and ServiceNow implementation, alongside cloud platforms for bioinformatics, signaling infrastructure modernization to support manufacturing and data science operations.
Notable leadership hires: Medical Director, CRM Business Lead, Patient CRM Lead, Cell Biology Lead, Sterility Assurance Lead
BioMarin discovers and commercializes targeted genetic therapies for rare genetic disorders, operating as a global public company with manufacturing, research, and regulatory operations across nine countries. The organization spans 1,001–5,000 employees with significant depth in operations, manufacturing, and research—reflecting the capital and compliance intensity of drug development and production. Current hiring velocity is accelerating across operations, manufacturing, and research roles, with notable focus on leadership positions in medical affairs, cell biology, and commercial organization. The company manages a pipeline of multiple product candidates alongside established marketed treatments, coordinating development, manufacturing scale-up, payer engagement, and product launches.
BioMarin uses SAP, Veeva QMS, Salesforce Health Cloud, LIMS, ServiceNow, SAS, R, Power BI, and emerging AI tools (Claude, GPT). The stack spans ERP (SAP), quality management, CRM, lab information systems, and data analytics—typical of regulated biotech manufacturing.
BioMarin has active hiring in nine countries: United States, Italy, Ireland, China, Japan, United Kingdom, Poland, Mexico, and Netherlands—reflecting global manufacturing and R&D footprint.
Other companies in the same industry, closest in size